FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Helmy Siragy

Research Profile

Anatomy

Living Beings

Chemicals & Drugs

Disorders

Physiology

Natriuresis

Phenomena

Renal Circulation

Co-author Network

Publications

TOP 3
Bernard Waeber; Helmy M Siragy
Mild hypertension: to treat or not to treat?
Luis C Matavelli; Helmy M Siragy
Reduction of aldosterone production improves renal oxidative stress and fibrosis in diabetic rats.
Luis C Matavelli; Jiqian Huang; Helmy M Siragy
In vivo regulation of renal expression of (pro)renin receptor by a low-sodium diet.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Helmy Siragy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Bernard Waeber; Helmy M Siragy
Mild hypertension: to treat or not to treat?
Current hypertension reports 2013;15(1):1-2.
2013: Luis C Matavelli; Helmy M Siragy
Reduction of aldosterone production improves renal oxidative stress and fibrosis in diabetic rats.
Journal of cardiovascular pharmacology 2013;61(1):17-22.
2012: Luis C Matavelli; Jiqian Huang; Helmy M Siragy
In vivo regulation of renal expression of (pro)renin receptor by a low-sodium diet.
American journal of physiology. Renal physiology 2012;303(12):F1652-7.
2012: Luis C Matavelli; Jiqian Huang; Helmy M Siragy
Combined aliskiren and amlodipine reduce albuminuria via reduction in renal inflammation in diabetic rats.
Journal of cardiovascular pharmacology 2012;59(3):281-7.
2012: Jiqian Huang; Helmy M Siragy
Sodium depletion enhances renal expression of (pro)renin receptor via cyclic GMP-protein kinase G signaling pathway.
Hypertension 2012;59(2):317-23.
2011: Helmy M Siragy
To ACCELERATE hypertension control.
Current hypertension reports 2011;13(4):259-61.
2011: Peter M Abadir; Jeremy Walston; Robert M Carey; Helmy M Siragy
Angiotensin II Type-2 receptors modulate inflammation through signal transducer and activator of transcription proteins 3 phosphorylation and TNFα production.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2011;31(6):471-4.
2011: Jiqian Huang; Luis C Matavelli; Helmy M Siragy
Renal (pro)renin receptor contributes to development of diabetic kidney disease through transforming growth factor-β1-connective tissue growth factor signalling cascade.
Clinical and experimental pharmacology & physiology 2011;38(4):215-21.
2011: Helmy M Siragy
Rationale for combining a direct renin inhibitor with other renin- angiotensin system blockers. Focus on aliskiren and combinations.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2011;25(1):87-97.
2011: Luis C Matavelli; Jiqian Huang; Helmy M Siragy
Angiotensin AT₂ receptor stimulation inhibits early renal inflammation in renovascular hypertension.
Hypertension 2011;57(2):308-13.
2011: Helmy M Siragy
A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors.
Vascular health and risk management 2011;7():297-313.
2010: Helmy M Siragy
ESCAPE: From hypertension to renal failure.
Current hypertension reports 2010;12(4):207-9.
2010: Jiqian Huang; Helmy M Siragy
Regulation of (pro)renin receptor expression by glucose-induced mitogen-activated protein kinase, nuclear factor-kappaB, and activator protein-1 signaling pathways.
Endocrinology 2010;151(7):3317-25.
2010: Helmy M Siragy
Comparing angiotensin II receptor blockers on benefits beyond blood pressure.
Advances in therapy 2010;27(5):257-84.
2010: Helmy M Siragy
The angiotensin II type 2 receptor and the kidney.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2010;11(1):33-6.
2010: Luis C Matavelli; Jiqian Huang; Helmy M Siragy
(Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation.
Clinical and experimental pharmacology & physiology 2010;37(3):277-82.
2010: Helmy M Siragy; Robert M Carey
Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease.
American journal of nephrology 2010;31(6):541-50.
2010: Helmy M Siragy
Improving vascular function in hypertension: potential benefits of combination therapy with amlodipine and renin-angiotensin-aldosterone system blockers.
Journal of hypertension 2010;28(1):2-8.
2009: Jiqian Huang; Helmy M Siragy
Glucose promotes the production of interleukine-1beta and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression.
Endocrinology 2009;150(12):5557-65.
2009: Helmy M Siragy
The potential role of the angiotensin subtype 2 receptor in cardiovascular protection.
Current hypertension reports 2009;11(4):260-2.
2009: Helmy M Siragy
ACCOMPLISH the goal: hypertension and beyond.
Current hypertension reports 2009;11(4):231-2.
2008: Emaad M Abdel-Rahman; Peter M Abadir; Helmy M Siragy
Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptors.
American journal of physiology. Regulatory, integrative and comparative physiology 2008;295(5):R1473-8.
2008: Helmy M Siragy
Evidence for benefits of angiotensin receptor blockade beyond blood pressure control.
Current hypertension reports 2008;10(4):261-7.
2008: Helmy M Siragy; Chun Xue
Local renal aldosterone production induces inflammation and matrix formation in kidneys of diabetic rats.
Experimental physiology 2008;93(7):817-24.
2008: Helmy M Siragy; Jiqian Huang
Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity.
Experimental physiology 2008;93(5):709-14.
2007: Helmy M Siragy
Angiotensin AT1 and AT2 receptors--the battle for health and disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(11):3128-30.
2007: Farah Ahmed; Brandon A Kemp; Nancy L Howell; Helmy M Siragy; Robert M Carey
Extracellular renal guanosine cyclic 3'5'-monophosphate modulates nitric oxide and pressure-induced natriuresis.
Hypertension 2007;50(5):958-63.
2007: Helmy M Siragy; Tadashi Inagami; Robert M Carey
NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats.
American journal of physiology. Regulatory, integrative and comparative physiology 2007;293(4):R1461-7.
2007: Helmy M Siragy
Renin inhibition: a new modality for hypertension management.
Current hypertension reports 2007;9(4):291-4.
2007: Helmy M Siragy
TROPHY for preventing hypertension.
Current hypertension reports 2007;9(4):259-60.
2007: Shetal H Padia; Brandon A Kemp; Nancy L Howell; Helmy M Siragy; Marie-Claude Fournie-Zaluski; Bernard P Roques; Robert M Carey
Intrarenal aminopeptidase N inhibition augments natriuretic responses to angiotensin III in angiotensin type 1 receptor-blocked rats.
Hypertension 2007;49(3):625-30.
2006: Helmy M Siragy
Does pharmacologic weight reduction improve blood pressure?
Current hypertension reports 2006;8(4):275-6.
2006: Peter M Abadir; Ammasi Periasamy; Robert M Carey; Helmy M Siragy
Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization.
Hypertension 2006;48(2):316-22.
2006: Helmy M Siragy
Hyponatremia, fluid-electrolyte disorders, and the syndrome of inappropriate antidiuretic hormone secretion: diagnosis and treatment options.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2006;12(4):446-57.
2006: Helmy M Siragy; Chun Xue; Randy L Webb
Beneficial effects of combined benazepril-amlodipine on cardiac nitric oxide, cGMP, and TNF-alpha production after cardiac ischemia.
Journal of cardiovascular pharmacology 2006;47(5):636-42.
2006: Shetal H Padia; Nancy L Howell; Helmy M Siragy; Robert M Carey
Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat.
Hypertension 2006;47(3):537-44.
2006: Helmy M Siragy
Angiotensin II compartmentalization within the kidney: effects of salt diet and blood pressure alterations.
Current opinion in nephrology and hypertension 2006;15(1):50-3.
2005: Chun Xue; Helmy M Siragy
Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor.
Hypertension 2005;46(3):584-90.
2005: Helmy M Siragy
Clinical trials report. Beta-blockade in diabetes: alleviating the concerns.
Current hypertension reports 2005;7(4):238-9.
2005: Alaa S Awad; Randy L Webb; Robert M Carey; Helmy M Siragy
Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats.
American journal of hypertension 2005;18(4 Pt 1):544-8.
2005: Helmy M Siragy; Chun Xue; Peter M Abadir; Robert M Carey
Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation.
Hypertension 2005;45(1):133-7.
2004: Helmy M Siragy
Clinical trials report. VALIANT: another milestone for angiotensin receptor blockers.
Current hypertension reports 2004;6(4):255-6.
2004: Alaa S Awad; Randy L Webb; Robert M Carey; Helmy M Siragy
Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade.
Journal of hypertension 2004;22(8):1571-7.
2004: Gary H Gibbons; Choong-Chin Liew; Mark O Goodarzi; Jerome I Rotter; Willa A Hsueh; Helmy M Siragy; Richard Pratt; Victor J Dzau
Genetic markers: progress and potential for cardiovascular disease.
Circulation 2004;109(25 Suppl 1):IV47-58.
2004: Xiao-Hong Jin; Helen E McGrath; John J Gildea; Helmy M Siragy; Robin A Felder; Robert M Carey
Renal interstitial guanosine cyclic 3', 5'-monophosphate mediates pressure-natriuresis via protein kinase G.
Hypertension 2004;43(5):1133-9.
2004: Helmy M Siragy
AT1 and AT2 receptor in the kidney: role in health and disease.
Seminars in nephrology 2004;24(2):93-100.
2004: Shota Sasaki; Helmy M Siragy; John J Gildea; Robin A Felder; Robert M Carey
Production and role of extracellular guanosine cyclic 3', 5' monophosphate in sodium uptake in human proximal tubule cells.
Hypertension 2004;43(2):286-91.
2003: Kambiz Kalantarinia; Alaa S Awad; Helmy M Siragy
Urinary and renal interstitial concentrations of TNF-alpha increase prior to the rise in albuminuria in diabetic rats.
Kidney international 2003;64(4):1208-13.
2003: Peter M Abadir; Robert M Carey; Helmy M Siragy
Angiotensin AT2 receptors directly stimulate renal nitric oxide in bradykinin B2-receptor-null mice.
Hypertension 2003;42(4):600-4.
2003: Lesley J Millatt; Guy St J Whitley; Dechun Li; James M Leiper; Helmy M Siragy; Robert M Carey; Roger Johns
Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
Circulation 2003;108(12):1493-8.
2003: Jack Knight-Scott; Andreana P Haley; Sarah R Rossmiller; Elana Farace; Vu M Mai; John M Christopher; Carol A Manning; Virginia I Simnad; Helmy M Siragy
Molality as a unit of measure for expressing 1H MRS brain metabolite concentrations in vivo.
Magnetic resonance imaging 2003;21(7):787-97.
2003: Robert M Carey; Helmy M Siragy
The intrarenal renin-angiotensin system and diabetic nephropathy.
Trends in endocrinology and metabolism: TEM 2003;14(6):274-81.
2003: Helmy M Siragy
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitors or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Current hypertension reports 2003;5(4):293-4.
2003: Robert M Carey; Helmy M Siragy
Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation.
Endocrine reviews 2003;24(3):261-71.
2003: Helmy M Siragy; Alaa Awad; Peter M Abadir; Randy Webb
The angiotensin II type 1 receptor mediates renal interstitial content of tumor necrosis factor-alpha in diabetic rats.
Endocrinology 2003;144(6):2229-33.
2002: Jack Knight-Scott; Elana Farace; Virginia I Simnad; Helmy M Siragy; Carol A Manning
Constrained modeling for spectroscopic measurement of bi-exponential spin-lattice relaxation of water in vivo.
Magnetic resonance imaging 2002;20(9):681-9.
2002: Helmy M Siragy
Angiotensin receptor blockers: how important is selectivity?
American journal of hypertension 2002;15(11):1006-14.
2002: Kambiz Kalantarinia; Helmy M Siragy
The choice of antihypertensive drugs in patients with diabetes: angiotensin II and beyond.
Current diabetes reports 2002;2(5):423-30.
2002: Helmy M Siragy; Mohamed A El-Kersh; Marc de Gasparo; Randy L Webb; Robert M Carey
Differences in AT2 -receptor stimulation between AT1 -receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP.
Journal of hypertension 2002;20(6):1157-63.
2001: Robert M Carey; Nancy L Howell; Xiao-Hong Jin; Helmy M Siragy
Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats.
Hypertension 2001;38(6):1272-7.
2001: Xiao-Hong Jin; Helmy M Siragy; Robert M Carey
Renal interstitial cGMP mediates natriuresis by direct tubule mechanism.
Hypertension 2001;38(3):309-16.
2001: Helmy M Siragy; Marc de Gasparo; M El-Kersh; Robert M Carey
Angiotensin-converting enzyme inhibition potentiates angiotensin II type 1 receptor effects on renal bradykinin and cGMP.
Hypertension 2001;38(2):183-6.
2001: Robert M Carey; Xiao-Hong Jin; Helmy M Siragy
Role of the angiotensin AT2 receptor in blood pressure regulation and therapeutic implications.
American journal of hypertension 2001;14(6 Pt 2):98S-102S.
2001: AF Moore; N T Heiderstadt; E Huang; Nancy L Howell; ZQ Wang; Helmy M Siragy; Robert M Carey
Selective inhibition of the renal angiotensin type 2 receptor increases blood pressure in conscious rats.
Hypertension 2001;37(5):1285-91.
2001: Helmy M Siragy; Robert M Carey
Angiotensin type 2 receptors: potential importance in the regulation of blood pressure.
Current opinion in nephrology and hypertension 2001;10(1):99-103.
2000: Lesley J Millatt; Helmy M Siragy
Renal cyclic 3',5'-guanosine monophosphate and sodium excretion in Dahl salt-resistant and Dahl salt-sensitive rats: comparison of the roles of bradykinin and nitric oxide.
Journal of hypertension 2000;18(10):1491-6.
2000: Helmy M Siragy
AT(1) and AT(2) receptors in the kidney: role in disease and treatment.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2000;36(3 Suppl 1):S4-9.
2000: Helmy M Siragy
The role of the AT2 receptor in hypertension.
American journal of hypertension 2000;13(5 Pt 2):62S-67S.
2000: Helmy M Siragy; Marc de Gasparo; Robert M Carey
Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats.
Hypertension 2000;35(5):1074-7.
2000: Robert M Carey; ZQ Wang; Helmy M Siragy
Update: role of the angiotensin type-2 (AT(2)) receptor in blood pressure regulation.
Current hypertension reports 2000;2(2):198-201.
2000: Helmy M Siragy; Robert M Carey
Prospective trials of angiotensin receptor blockers: beyond blood pressure control.
Current hypertension reports 2000;2(2):163-4.
2000: Lesley J Millatt; Helmy M Siragy
Age-related changes in renal cyclic nucleotides and eicosanoids in response to sodium intake.
Hypertension 2000;35(2):643-7.
2000: Robert M Carey; X Jin; Z Wang; Helmy M Siragy
Nitric oxide: a physiological mediator of the type 2 (AT2) angiotensin receptor.
Acta physiologica Scandinavica 2000;168(1):65-71.
2000: Robert M Carey; ZQ Wang; Helmy M Siragy
Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function.
Hypertension 2000;35(1 Pt 2):155-63.
1999: Helmy M Siragy
Angiotensin II receptor blockers: review of the binding characteristics.
The American journal of cardiology 1999;84(10A):3S-8S.
1999: Helmy M Siragy; M Bedigian
Mechanism of action of angiotensin-receptor blocking agents.
Current hypertension reports 1999;1(4):289-95.
1999: Helmy M Siragy; Takaaki Senbonmatsu; Toshihiro Ichiki; Tadashi Inagami; Robert M Carey
Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor.
The Journal of clinical investigation 1999;104(2):181-8.
1999: Lesley J Millatt; Emaad Abdel-Rahman; Helmy M Siragy
Angiotensin II and nitric oxide: a question of balance.
Regulatory peptides 1999;81(1-3):1-10.
1999: Helmy M Siragy; Tadashi Inagami; Toshihiro Ichiki; Robert M Carey
Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(11):6506-10.
1999: Helmy M Siragy; Robert M Carey
Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model.
Hypertension 1999;33(5):1237-42.
1999: Robert M Carey; ZQ Wang; Helmy M Siragy
Novel actions of angiotensin II via its renal type-2 (AT(2)) receptor.
Current hypertension reports 1999;1(2):151-7.
1999: ZQ Wang; Lesley J Millatt; N T Heiderstadt; Helmy M Siragy; Roger Johns; Robert M Carey
Differential regulation of renal angiotensin subtype AT1A and AT2 receptor protein in rats with angiotensin-dependent hypertension.
Hypertension 1999;33(1):96-101.
1999: Xiao-Hong Jin; Helmy M Siragy; Richard L Guerrant; Robert M Carey
Compartmentalization of extracellular cGMP determines absorptive or secretory responses in the rat jejunum.
The Journal of clinical investigation 1999;103(2):167-74.
1998: Xiao-Hong Jin; ZQ Wang; Helmy M Siragy; Richard L Guerrant; Robert M Carey
Regulation of jejunal sodium and water absorption by angiotensin subtype receptors.
The American journal of physiology 1998;275(2 Pt 2):R515-23.
1998: ZQ Wang; AF Moore; Ryoji Ozono; Helmy M Siragy; Robert M Carey
Immunolocalization of subtype 2 angiotensin II (AT2) receptor protein in rat heart.
Hypertension 1998;32(1):78-83.
1998: C Zitnay; Helmy M Siragy
Action of angiotensin receptor subtypes on the renal tubules and vasculature: implications for volume homeostasis and atherosclerosis.
Mineral and electrolyte metabolism 1998;24(6):362-70.
1998: Robert M Carey; ZQ Wang; Helmy M Siragy; Robin A Felder
Renal dopamine production and release in the rat: a microdialysis study.
Advances in pharmacology (San Diego, Calif.) 1998;42():873-6.
1997: Ryoji Ozono; ZQ Wang; AF Moore; Tadashi Inagami; Helmy M Siragy; Robert M Carey
Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney.
Hypertension 1997;30(5):1238-46.
1997: Helmy M Siragy; Robert M Carey
The subtype 2 angiotensin receptor regulates renal prostaglandin F2 alpha formation in conscious rats.
The American journal of physiology 1997;273(3 Pt 2):R1103-7.
1997: Helmy M Siragy; Robert M Carey
The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
The Journal of clinical investigation 1997;100(2):264-9.
1997: Helmy M Siragy; Ayad A Jaffa; Harry S Margolius
Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide.
Hypertension 1997;29(3):757-62.
1997: ZQ Wang; Helmy M Siragy; Robin A Felder; Robert M Carey
Intrarenal dopamine production and distribution in the rat. Physiological control of sodium excretion.
Hypertension 1997;29(1 Pt 2):228-34.
1997: ZQ Wang; Helmy M Siragy; Robin A Felder; Robert M Carey
Preferential release of renal dopamine into the tubule lumen: effect of chronic sodium loading.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1997;19(1-2):107-16.
1996: Helmy M Siragy; Ayad A Jaffa; Harry S Margolius; Robert M Carey
Renin-angiotensin system modulates renal bradykinin production.
The American journal of physiology 1996;271(4 Pt 2):R1090-5.
1996: Helmy M Siragy; Robert M Carey
The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats.
The Journal of clinical investigation 1996;97(8):1978-82.
1996: Helmy M Siragy; J Linden
Sodium intake markedly alters renal interstitial fluid adenosine.
Hypertension 1996;27(3 Pt 1):404-7.
1995: Helmy M Siragy; N L Howell; N V Ragsdale; Robert M Carey
Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition.
Hypertension 1995;25(5):1021-4.
1995: Helmy M Siragy; W V Vieweg; S Pincus; Johannes D Veldhuis
Increased disorderliness and amplified basal and pulsatile aldosterone secretion in patients with primary aldosteronism.
The Journal of clinical endocrinology and metabolism 1995;80(1):28-33.
1994: Helmy M Siragy; M M Ibrahim; Ayad A Jaffa; Ronald Mayfield; Harry S Margolius
Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3',5'-monophosphate. Effects of altered sodium intake.
Hypertension 1994;23(6 Pt 2):1068-70.
1993: Helmy M Siragy; Ayad A Jaffa; Harry S Margolius
Stimulation of renal interstitial bradykinin by sodium depletion.
American journal of hypertension 1993;6(10):863-6.
1993: Helmy M Siragy
Evidence that intrarenal bradykinin plays a role in regulation of renal function.
The American journal of physiology 1993;265(4 Pt 1):E648-54.
1993: JE Humphries; Helmy M Siragy
Significant hyponatremia following DDAVP administration in a healthy adult.
American journal of hematology 1993;44(1):12-5.
1992: Helmy M Siragy; Robin A Felder; M J Peach; Robert M Carey
Intrarenal DA2 dopamine receptor stimulation in the conscious dog.
The American journal of physiology 1992;262(6 Pt 2):F932-8.
1992: Helmy M Siragy; Roger Johns; M J Peach; Robert M Carey
Nitric oxide alters renal function and guanosine 3',5'-cyclic monophosphate.
Hypertension 1992;19(6 Pt 2):775-9.
1992: Helmy M Siragy
Endothelium-derived relaxing factor modulates renal interstitial cyclic GMP.
Journal of cardiovascular pharmacology 1992;20 Suppl 12():S163-5.
1990: Helmy M Siragy; Robin A Felder; N L Howell; Robert L Chevalier; M J Peach; Robert M Carey
Evidence that dopamine-2 mechanisms control renal function.
The American journal of physiology 1990;259(5 Pt 2):F793-800.
1990: Robert M Carey; Helmy M Siragy; N V Ragsdale; N L Howell; Robin A Felder; M J Peach; Robert L Chevalier
Dopamine-1 and dopamine-2 mechanisms in the control of renal function.
American journal of hypertension 1990;3(6 Pt 2):59S-63S.
1990: Helmy M Siragy; N L Howell; M J Peach; Robert M Carey
Combined intrarenal blockade of the renin-angiotensin system in the conscious dog.
The American journal of physiology 1990;258(3 Pt 2):F522-9.
1990: Robert M Carey; Helmy M Siragy; Robin A Felder
Physiological modulation of renal function by the renal dopaminergic system.
Journal of autonomic pharmacology 1990;10 Suppl 1():s47-51.
1989: Helmy M Siragy; N L Howell; M J Peach; Robert M Carey
Combined intrarenal renin-angiotensin blockade alters renal function and this is reversed by angiotensin II.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S174-5.
1989: Helmy M Siragy; Robin A Felder; N L Howell; Robert L Chevalier; M J Peach; Robert M Carey
Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule.
The American journal of physiology 1989;257(3 Pt 2):F469-77.
1988: Helmy M Siragy; Robin A Felder; N E Howell; Robert L Chevalier; M J Peach; Robert M Carey
Intrarenal dopamine acts at the dopamine-1 receptor to control renal function.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S479-81.
1988: Helmy M Siragy; N E Lamb; C E Rose; M J Peach; Robert M Carey
Intrarenal renin inhibition increases renal function by an angiotensin II-dependent mechanism.
The American journal of physiology 1988;255(4 Pt 2):F749-54.
1988: Helmy M Siragy; N E Lamb; C E Rose; M J Peach; Robert M Carey
Angiotensin II modulates the intrarenal effects of atrial natriuretic peptide.
The American journal of physiology 1988;255(3 Pt 2):F545-51.
1988: Helmy M Siragy; N Howell; C E Rose; M C Khosla; M J Peach; Robert M Carey
Intrarenal effects of [Ala-Pro-Gly-(Ile3-Val5)] angiotensin II in the conscious dog.
Endocrinology 1988;122(1):359-63.
1988: Helmy M Siragy; Robin A Felder; N L Howell; Robert L Chevalier; M J Peach; Robert M Carey
Intrarenal dopamine-1 receptors control renal function.
Transactions of the Association of American Physicians 1988;101():288-91.
1987: Helmy M Siragy; N E Lamb; J F Woodson; N V Ragsdale; C E Rose; M J Peach; Robert M Carey
Renal sensitivity to angiotensin II in the conscious dog.
Endocrinology 1987;120(4):1272-8.